Linker length dependent binding of a focal adhesion kinase derived peptide to the Src SH3–SH2 domains  by Lindfors, Hanna E. et al.
FEBS Letters 585 (2011) 601–605journal homepage: www.FEBSLetters .orgLinker length dependent binding of a focal adhesion kinase derived peptide
to the Src SH3–SH2 domains
Hanna E. Lindfors a, Bharat Somireddy Venkata a, Jan W. Drijfhout b, Marcellus Ubbink a,⇑
a Leiden University, Leiden Institute of Chemistry, P.O. Box 9502, 2300 RA Leiden, The Netherlands
bDepartment of Immunohematology and Bloodtransfusion, Leiden University Medical Center, Leiden, The Netherlandsa r t i c l e i n f o
Article history:
Received 30 November 2010
Revised 17 January 2011
Accepted 18 January 2011
Available online 23 January 2011





Biophysics0014-5793/$36.00  2011 Federation of European Bio
doi:10.1016/j.febslet.2011.01.026
⇑ Corresponding author. Fax: +31 71 5275856.
E-mail address: m.ubbink@chem.leidenuniv.nl (M.a b s t r a c t
The interaction between a peptide encompassing the SH3 and SH2 binding motifs of focal adhesion
kinase (FAK) and the Src SH3–SH2 domains has been investigated with NMR spectroscopy and cal-
orimetry. The binding to both motifs is anti-cooperative. Reduction of the long linker connecting
the motifs does not lead to cooperativity. Short linkers that do not allow simultaneous intramolec-
ular binding of the peptide to both motifs cause peptide-mediated dimerisation, even with a linker
of only three amino acids. The role of the SH3 binding motif is discussed in view of the independent
nature of the SH interactions.
Structured summary:
FAK_p3 and Src bind by nuclear magnetic resonance (View interaction)
FAK_p2 and Src bind by nuclear magnetic resonance (View interaction)
FAK_p32 and Src bind by nuclear magnetic resonance (View interaction)
FAK_p2 and Src bind by isothermal titration calorimetry (View interaction)
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The Src family kinases (SFKs) are prototypical modular signal-
ling proteins. SFKs share a common domain structure with an N-
terminal myristoylation site, followed by a region that is unique
for each family member, a Src homology 3 (SH3) domain, a Src
homology 2 (SH2) domain, a tyrosine kinase domain and a C-ter-
minal region containing a self-inhibitory tyrosine residue [1]. The
SH3 and SH2 domains are protein-interaction domains found in a
large number of signalling proteins [2]. SH3 domains, ﬁrst discov-
ered in 1988 [3], bind to proline-rich sequences that adopt a left-
handed helical conformation [4], whereas SH2 domains recognize
phosphorylated tyrosine residues. The SH2 and SH3 domains play
a role both in regulating kinase activity and in recognition of sub-
strates [5]. Fragments encompassing the SH3–SH2 domains
(SH3SH2) from several SFKs have been characterized biochemi-
cally, structurally and computationally [6–14], because of the
importance of these domains for the functioning of SFKs. Another
tyrosine kinase, focal adhesion kinase (FAK), activates the SFKs
Src and Fyn via interactions with their SH2 and SH3 domains
[8,9,15]. The linker region between the FERM (4.1 protein, ezrin,
radixin, moesin; residues 35–355 for human FAK) and catalytic do-chemical Societies. Published by E
Ubbink).main (residues 420–680) of FAK contains a tyrosine residue, Y397,
which becomes phosphorylated in connection with FAK activation
[16]. N-Terminal to the tyrosine, the linker contains a proline-rich
region of the sequence RALPSIPKL (residues 368–376). These resi-
dues contain the SH3 domain binding motif PxxP [17], whereas
the phosphotyrosine region with sequence pYAEI is close to the
consensus sequence for SH2 domain binding [18]. Peptides derived
from FAK spanning both the proline-rich and phosphotyrosine
sites have been shown to bind to SH3SH2 fragments in a bidentate
manner [8,9]. It has been demonstrated that the interaction be-
tween the FAK peptide and the Fyn SH3SH2 domains is restricted
to the canonical SH3 and SH2 binding sites and that the interaction
does not affect the dynamic independence of the two domains [9].
The SH3 and SH2 domain binding motifs in the FAK fragment are
separated by 22 amino acids, approximately 10 residues more than
required to span the distance between the peptide-binding faces
on the SH3 and SH2 domains [9]. This allows for simultaneous
association of the SH3 and SH2 domains with their respective bind-
ing sites in the peptide. The presence of an SH3 binding motif is,
however, somewhat puzzling, because SH3 interactions are weak
compared to those of the SH2 domain and thus contribute little
to the binding afﬁnity. Furthermore, the long spacer separating
the binding motifs would be expected to abolish or at least reduce
the potential for cooperative binding, as has been reported for Fyn
[9]. Here, we report on NMR and ITC experiments on the interac-lsevier B.V. All rights reserved.
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based on the FAK binding motifs, separated by increasingly shorter
spacers. The full length spacer ensures that both motifs bind to the
SH3 and SH2 domains of the same protein molecule. Reduction of
spacer length does not lead to cooperative binding. With short
spacers peptide-mediated SH3–SH2 dimerisation becomes promi-
nent. Interestingly, even with a spacer of only three amino acids
dimerisation is observed.
2. Materials and methods
2.1. Materials
Protein production and peptide synthesis are described in the
Supplementary material.
2.2. Nuclear magnetic resonance spectroscopy
NMR samples contained the 15N-labelled protein in 20 mM
potassium phosphate pH 6.5, 100 mM NaCl, 1 mM DTT and 6%
D2O. All NMR experiments were performed at 303 K on a Bruker
DMX600 spectrometer equipped with a TCI-Z-GRAD cryoprobe
(Bruker, Karlsruhe, Germany). The data were processed with Azara
(http://www.bio.cam.ac.uk/azara/) and analyzed using Ansig for
Windows [19].
Assignments were based on published work and checked with
3D NOESY-HSQC and 3D TOCSY-HSQC spectra recorded on a 15N
SH3SH2 sample. Peptide titrations were performed through the
addition of microliter aliquots of peptide stock solution with a con-
centration ranging from 1 to 5 mM to an SH3SH2 sample of
200 lM. Two-dimensional [15N,1H]-HSQC spectra were recorded
at every step of the titration. Chemical shift perturbation (CSP)
analysis is described in the Supplementary material.
2.3. Isothermal titration calorimetry
Isothermal titration calorimetry (ITC) experiments were per-
formed at 303 K in solutions of 20 mMHEPES pH 6.8, 100 mMNaCl
and 1 mM TCEP on a Microcal (Northampton, MA) VP-ITC micro-
calorimeter. Experimental details can be found in the Supplemen-
tary material.
3. Results and discussion
NMR titrations and ITC experiments were performed to charac-
terize the interactions between the Src SH3SH2 protein fragment
and peptides derived from the SH3 and SH2 domain binding sites
in FAK, with gradually shorter spacers between the binding sites
(Table 1). The control peptides p2 and p3 comprise the isolatedTable 1
Peptides derived from FAK (SH3 and SH2 binding motifs underlined) with the
and the SH2 binding site (pYAEI). The peptides containing only the SH3 or SH












p3 RALPSIPKLSH2 and SH3 binding motifs of FAK, respectively. Peptide p2 binds
to the SH3SH2 protein with an equilibrium dissociation constant
(Kd) of 140 nM (Table 2 and Fig. S1) and the interaction is in the
slow exchange regime on the NMR time scale (Fig. 1). In contrast,
peptide p3 binds to the SH3 domain with a Kd of 212 lM, three or-
ders of magnitude higher. Association and dissociation are fast on
the NMR time-scale.
Titrations of SH3SH2 with peptide p32, which contains both the
SH3 and SH2 binding motifs separated by the full-length sequence
as found in FAK, leads to chemical shift perturbations (CSPs) in the
SH3 and SH2 domains that are similar to those caused by peptides
p3 and p2 (Fig. 2), indicating that the p32–SH3SH2 interaction is
conﬁned to the SH3 and SH2 peptide binding sites on the protein.
The chemical exchange behaviour for SH3 amides in the titration
with p32 is slow, contrary to that observed in the titration with
p3 (Fig. 1), because exchange of p32 between protein molecules
is limited by the slow release from the SH2 binding site.
Due to solubility problems for the longest peptides p32 and p-3,
no high-quality ITC data could be obtained for these peptides. For
peptide p-7, which is still long enough to span the distance be-
tween the SH3 domain and SH2 domain peptide binding sites on
the SH3SH2 protein, ITC data (Fig. S1) were ﬁtted to a one-site
binding model, yielding a Kd of 28 nM (Table 2). This value agrees
well with those determined with surface plasmon resonance and
ITC by Thomas et al. [8] and Arold et al. [9], for the binding of
the Src and Fyn SH3SH2 domains to a FAK peptide containing both
the SH3 and SH2 binding sites. Comparison with the results for p3
or p2 binding to SH3SH2 shows that the free energy change upon
binding the peptide containing both an SH3 and SH2 binding motif
is less than the sum of the free energy changes upon binding p2
and p3 (Table 2), indicating that the binding is anti-cooperative.
This result is in agreement with what has been shown for the
SH3SH2 domains of Fyn. It was proposed that restriction of the
conformational freedom of the FAK peptide, together with possible
binding-induced partial structure in the peptide, causes a small
entropic penalty [9]. In the absence of favourable contributions
from additional contacts outside the SH3 and SH2 binding sites,
this leads to anti-cooperative binding. However, in contrast to
the Fyn-FAK data, our results indicate an enthalpic penalty. The en-
tropy term for p-7 binding equals the sum of those for p2 and p3
binding.
Examination of the exchange characteristics of SH2 and SH3
resonances in NMR titrations with gradually shorter peptides into
an SH3SH2 sample shows that for all peptides containing the phos-
photyrosine the SH2 domain resonances remain in slow exchange.
The SH3 resonances show the features of increasing exchange rates
with decreasing linker length (Fig. 3).
For the shorter peptides, such as p-17 and p-19, the distance be-
tween the two binding motifs is too small for the peptide to bind todecreasing length of the spacer between the SH3 binding site (RALPSIP)
2 binding motif are also shown. pY denotes a phosphotyrosine residue.
tively.
Number of residues removed













Thermodynamic parameters for peptides binding to Src SH3SH2. Uncertainties in K,
DH and DG are the standard deviations of three experiments, the uncertainty in TDS
was calculated using standard error propagation.






p3 2.1 ± 0.1  104 15.5 ± 0.7 10.4 ± 0.7 5.1 ± 0.1
p2 1.4 ± 0.5  107 9.4 ± 0.3 0.1 ± 0.4 9.4 ± 0.1
p-7 2.8 ± 0.3  108 20.5 ± 0.3 10.1 ± 0.3 10.5 ± 0.1
p-19 4.2 ± 0.2  107 12.1 ± 0.1 3.2 ± 0.1 8.8 ± 0.1
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peptide binding. Rearrangement of the SH3 and SH2 domains to al-
low for simultaneous binding would require substantial domain
movements, which would be reﬂected in considerable chemical
shift perturbations of the residues linking the domains. The chem-
ical shift perturbations for most of these residues are small, how-
ever. Thus, it was expected that in a titration p-17 and p-19
would ﬁrst ﬁll the high afﬁnity site on the SH2 domain and only
bind to the SH3 domain when the peptide–protein ratio was larger
than one.
However, CSPs were observed for SH3 resonances already at low
ratios (Fig. 4, inset). Apparently, the SH3 domain is able to bind the
short peptides, even when the latter are bound to the SH2 binding
site. Intramolecular binding is not possible for these peptides, soFig. 1. Detail from HSQC spectra of Src SH3SH2 in titrations with peptides (A) p3, (B) p2
points (free protein) in black and titration end points shown in purple. Residues T17 an
Fig. 2. Average CSP in Src SH3SH2 caused by peptide binding are colour-coded on the p
ratio of 10:1; (B) peptide p2 at a ratio of 5:1; (C) peptide p32 at a ratio 1.5:1; (D) peptide p
0.1 > DdavgP 0.04 ppm; blue: Ddavg < 0.04 ppm. Non-assigned residues are shown in grwe inferred that intermolecular binding, i.e., peptide mediated
SH3SH2 dimerisation, must be occurring at low peptide-to-protein
ratios. At ratios well above equimolar, the excess of peptide enables
the formation of complexes of two peptidemolecules to one protein
molecule. Consequently, the binding behaviour is expected to be at
least biphasic for the CSPs of SH3 domain residues. One Kd describes
the binding of an SH3 domain to a peptide already bound via its
phosphotyrosine to another proteinmolecule (KSH3d1 ) and another re-
lates to SH3 domain binding to a free peptide (KSH3d2 ). The model is
illustrated in Fig. 5. The CSP shown in Fig. 4 for peptide p-19 cannot
be ﬁtted with a standard 1:1 binding curve (dotted line). A global
simulation on the basis of the model reproduces the data well, as
shown for the three residues, yielding KSH3d1 = 550 lM and
KSH3d2 = 190 lM. Interestingly, the maximum CSP for residues Thr33
and Gly35, both in the SH3 domain, are the same for both phases
(Dd11 = Dd
2
1, Eq. (S2)). The mode of peptide binding on the SH3 do-
main is apparently the same in both types of complexes. For the
15N amide nucleus of linker residue Thr166, this is not the case, with
Dd11 = 1.2 and Dd21 = 0.52 ppm. Similar results were found for
peptide p-17, with KSH3d1 = 410 lM and K
SH3
d2 = 105 lM (Fig. S2). The
control peptide p-19⁄, in which the tyrosine is not phosphorylated,
showed only CSP on the SH3 domain, indicating that SH2 binding
was abolished. It exhibited a standard 1:1 binding curve for SH3 do-
main binding, with Kd = 116 lM (Fig. S3).
ITC experiments for peptide p-19 interacting with SH3SH2
yielded a single binding site with a Kd value of 0.4 lM (Table 2and (C) p32. Spectra from several titration points are shown overlaid, with starting
d G155 are in the SH3 and SH2 binding sites, respectively.
rotein surface (PDB entry 1FMK [20]). (A) Peptide p3 at a peptide-to-protein molar
-19 at a ratio of 10:1. Red: DdavgP 0.3 ppm; orange: 0.3 >DdavgP 0.1 ppm; yellow:
ey. The ﬁgure was generated using PyMol (DeLano Scientiﬁc, Palo Alto).
Fig. 3. Detail from HSQC spectra of Src SH3SH2 showing SH3 domain residue G35 in titrations with peptides with decreasing separation between the SH2 and SH3 binding
motifs (A–H). A titration with peptide p3, containing only the SH3-binding site, is shown in I. Spectra from several titration points are shown overlaid, with starting points
(free protein) in black and titration end points shown in purple.
Fig. 4. Chemical shift perturbations for several 15N amide nuclei in SH3SH2 upon
titration with peptide p-19. The solid line and circles represents the data simulated
with the model discussed in the text, with KSH3d1 = 550 lM and K
SH3
d2 = 190 lM. The
best global ﬁt to a 1:1 binding model is shown as a dotted line. The inset shows the
lower part of the graph plotted on a linear scale.
Fig. 5. Model of two-phase peptide binding. SH3-mediated dimer formation occurs
with KSH3d1 and binding of an SH3 domain to a free peptide occurs with K
SH3
d2 . The
dissociation constant for peptide bound to the SH2 domain is KSH2d .
604 H.E. Lindfors et al. / FEBS Letters 585 (2011) 601–605and Fig. S1), close to the value for peptide p2. Apparently, the ITC
experiment only detects the binding of the SH2 domain to the pep-
tide and is insensitive for the additional weak SH3 domain binding.
The results of this study demonstrate that a reduction of the lin-
ker length between the SH3 and SH2 binding motifs in FAK does
not increase the afﬁnity for the SH3 domain. Fig. 3 shows that
the dissociation rate for the SH3 domain increases, even for the
slight reductions in linker length. For the long peptides, binding
simultaneously to the SH3 and SH2 domains of SH3SH2, associa-
tion to the SH3 domain occurs in the slow exchange regime,
whereas for the peptides that only bind the SH3 domain (p3, p-19⁄) the fast exchange regime is observed. This ﬁnding indicates
that SH3 binding in the long peptides is coupled to SH2 binding
and thus must occur within the same SH3SH2molecule. Upon tight
binding to the SH2 domain, the ‘local concentration’ of the SH3 do-
main of the same SH3SH2 molecule is very high and outcompetes
binding to the SH3 domain of a second SH3SH2 molecule.
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neous intramolecular binding to both domains showed, however,
that the SH3SH2 dimer formation readily occurs in that case, even
with a linker that separates the SH3 and SH2 binding motifs by
merely three residues (peptide p-19), as is illustrated by Fig. 4
and Fig. S2.
These ﬁndings raise the question why the SH3 binding site is
present in FAK. The afﬁnity for the SH2 site is about three orders
of magnitude greater, so the contribution to the free energy of
binding of the SH3 interaction is negligible. In fact, the binding of
both domains exhibits negative cooperativity, at least for the FAK
peptide. The structural independence of the binding to the two
Src domains, as evident from the binding maps (Fig. 1) and dimer-
isation behaviour of the short peptides, lead us to speculate that
the SH3 binding could be important in a situation in which
Tyr397 is not (yet) phosphorylated or unavailable and thus the
interaction with the SH2 is insigniﬁcant or does not occur. It is
known that FAK activation occurs as a combination of autophos-
phorylation and interaction with Src. Perhaps colocalisation and
the initial weak FAK–Src SH3 interaction form the ﬁrst step in
the FAK activation process. This hypothesis is currently under
investigation.Acknowledgements
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